Company: DVAX
Filing Date: 2025-04-03
Form Type: PREC14A
Source: 0000930413-25-001153
Chunk: 72

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-03
Form: PREC14A
Chunk 72
---
 102.50 | % |     | $    | 217,300 |     |                                 | 102.50 | % |     | $    | 54,325 |     | $        | 271,625 |    |
| Robert Janssen, M.D. |     |                              | 50 | % |     | $    | 271,146 |    |     |                                        | 102.50 | % |     | $    | 222,339 |     |                                 | 102.50 | % |     | $    | 55,585 |     | $        | 277,924 |    |

| (1) | Amounts are rounded to nearest dollar.                                                                                           |
| (2) | Messrs. Spencer and Novack did not have separate individual goals. Their incentive cash compensation was tied 100% to            
 achievement of corporate goals.                                                                                                  |
| (3) | Ms. MacDonald’s 2024 target annual cash incentive was less than 50% of her annualized base salary for 2024 because               
 the amount of base salary she was entitled to be paid by the Company for 2024 was reduced by certain California benefit payments 
 that she received in connection with her maternity leave during 2024.                                                            |
| (4) | The Company would have paid Ms. MacDonald additional salary in 2024, and thus have paid her a larger annual cash incentive       
 for 2024, if she had lived in a state that did not provide benefit payments for maternity leave, as her base salary would        
 not have been reduced while she was on paid maternity leave for the receipt of state benefit payments. Following Company policy, 
 and to avoid penalizing Ms. MacDonald for living in a state that provides benefit payments for maternity leave, we paid Ms.      
 MacDonald a supplemental bonus of $6,642 in addition to the $239,408 annual cash incentive paid to her for 2024 corporate        
 and individual performance.                                                                                                      |

Long-Term Equity Incentive Awards

2024 Equity Awards

In making annual long-term equity incentive
awards to our NEOs in early 2024, the Compensation Committee considered each NEO’s total equity outstanding as of December
31, 2024, individual performance during 2023, the potential amount that could be realized at different hypothetical stock prices
upon exercise or vesting of those awards and each NEO’s percentage of ownership of the Company. The Compensation Committee
also reviewed market and peer